Crescent Biopharma, Inc. (CBIO)
NASDAQ·Healthcare·Biotechnology
$24.12
-4.12%
Mkt Cap $683.41M
Next Earnings
In 14 daysWed, May 13, 2026
EPS Estimate
-$0.85
4 analysts
Revenue Estimate
$357.14K
Last quarter: missed by -80.63% on EPS, +8.44% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$683.41M
P/E
1062.45
Fwd P/E
—
P/S
16.50
Rev TTM
—
EPS TTM
$0.02